Propanc Biopharma, Inc.

Latest News

May 6, 2019

Propanc Biopharma Appoints Dr. Ralf Brandt to its Scientific Advisory Board

Dr. Brandt to Provide Translational Research Expertise and Clinical Support Advisory Services MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc”), a…

View All Press Releases

Mar 25, 2019

Propanc Biopharma Initiates Development of Bio-Analytical Assay in Preparation for Human Trials

Mar 13, 2019

Propanc Biopharma Receives Notice of Allowance for Additional Claims from Foundation Patent in the U.S.

Mar 5, 2019

Propanc Biopharma to Present at the 31st Annual ROTH Conference March 17 – 19, 2019
Latest Publication Antitumour efficacy of chymotrypsinogen and trypsinogen View All Publications
In vitro treatment of carcinoma cell lines with pancreatic (pro)enzymes suppresses the EMT programme and promotes cell differentiation
A formulation of pancreatic pro-enzymes provides potent anti-tumour efficacy: a pilot study focused on pancreatic and ovarian cancer